All Virology articles – Page 2
-
NewsStunningly detailed blueprint revealed of viral genome replication machinery
Scientists have shed new light on the crucial early stages of RNA virus infection and their control.
-
NewsResearchers develop electrochemical biosensor for flu antibody detection
A new testing method uses an electrochemical cell-free biosensor that can directly detect antibodies against diseases such as influenza in blood serum.
-
NewsChange in genetics of SARS-CoV-2 evolved to counter weakness caused by the virus’s initial mutation
Researchers at Johns Hopkins Medicine say their new studies suggest that the first pandemic-accelerating mutation in the SARS-CoV-2 virus, which causes COVID-19, evolved as a way to correct vulnerabilities caused by the mutation that started the SARS-CoV-2 pandemic.
-
OpinionManufacturing certainty on the origin of Covid-19 is damaging to science
Alina Chan reveals why it’s dangerous to insist that the lab leak theory is dead in the water.
-
NewsSimple nasal swab can provide early warning of emerging viruses
Testing for the presence of a single immune system molecule on nasal swabs can help detect stealthy viruses not identified in standard tests, Yale researchers have found.
-
NewsOlfactory viral inflammation linked to accelerated onset of Alzheimer’s disease
Viruses can inflame and disrupt connections between the olfactory system, which governs the sense of smell, and the part of the brain associated with memory and learning, possibly accelerating the onset of Alzheimer’s disease, according to a new study.
-
NewsScientists identify infection-halting compound that can target hosts, not viruses
Researchers at UBC’s Life Sciences Institute have identified a compound that shows early promise at halting infections from a range of coronaviruses, including all variants of SARS-CoV-2 and the common cold.
-
NewsPhase 2 trial of Ebola vaccines yields promising results
An international team of scientists has published the results of a large-scale randomized clinical trial in West Africa which confirms the safety of three vaccine regimens for Ebola and suggests an immune response is induced and maintained for up to 12 months.
-
NewsResearchers infect ‘brain in a dish’ in pursuit of Zika antivirals
A University of Queensland-led project has used a ‘brain in a dish’ to study the effects of the Zika virus, taking research a step closer towards developing drugs to combat the infection.
-
NewsPotential drug takes aim at emerging Chikungunya virus
Researchers are developing what could become the first-ever treatment against the debilitating joint pain that can last months or years after becoming infected with the emerging Chikungunya virus.
-
News New virus discovered in Swiss ticks
Researchers from the Institute of Virology at the University of Zurich (UZH) have detected the Alongshan virus (ALSV) for the first time in ticks in Switzerland.
-
NewsResearchers find new viral entryway into host cells for Covid-19
A University of Ottawa-led team has found a new viral entry for SARS-CoV-2, suggesting it may be able to use proteins to infect a wider range of cells.
-
NewsImmune response discovery solves mystery of why colds are more common when it’s cold
Scientists say a newly discovered immune response inside the nose is suppressed by colder temperatures, offering evidence for why colds, flu and COVID-19 are more common in cooler months.
-
NewsClover’s vaccine candidate reduced household transmission of SARS-CoV-2
A collaboration between Clover Biopharmaceuticals Ltd and the International Vaccine Institute showed that a household contact was 84% less likely to get a SARS-CoV-2 infection when the infected household member had received SCB-2019 (CpG 1018/Alum) compared to placebos.
-
NewsCOVID-19 infection disrupts gut microbes, especially with antibiotics
Acute infection disrupts a healthy balance between good and bad microbes in the gut, especially with antibiotic treatment, researchers have found.
-
NewsResearchers develop tailored Covid neutralizer that can adapt to mutations
A research team at Pohang University of Science and Technology has developed a tailored COVID-19 neutralizer that can adapt to all kinds of mutations in the virus in treating the viral infection.
-
NewsNew Omicron subvariant resistant to all approved therapeutic antibodies
Rrsearchers in Germany have found that the Omicron sub-lineage BQ.1.1, currently on the rise worldwide, is resistant to all the approved antibody therapies used to treat individuals at risk for severe Covid-19 disease.
-
NewsHidden Nsp1 cavity means Covid’s Spike protein is no longer the only target
Researchers have revealed the existence of a hidden ’’pocket’ on the surface of the non-structural protein Nsp1 on the surface of the Covid-19 virus which could offer a potential drug target and alternative to the Spike protein targeted by vaccines.
-
NewsHIV infection leaves memory that persists in cells even when virus is gone
A new study explains why people living with HIV may suffer from chronic inflammation, which can put them at an increased risk of developing comorbidities such as cardiovascular disease and neurocognitive dysfunction and how suppression or even eradication of HIV in the body may not resolve it. ...
-
NewsGene-delivering viruses cross into brain in step toward gene therapy for neurological diseases
A family of adeno-associated viruses (AAVs) has been developed that are capable of delivering gene therapies to the brain, a particularly challenging target tissue.
- Previous Page
- Page1
- Page2
- Page3
- Next Page
